Promising data from Phase 2 study in myelodyspla
Browsing: All news
Category Added in a WPeMatico Campaign
Company continues to advance NLRP3 neuroinflamma
Antag lands €80m to advance GIPR antagonist ap
World’s largest longevity event combines longe
Funding call for innovative scientific proposals